Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Steiger

Showing results (141-150 of 370) with videos related to

Pageof 37
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized DiseaseJulia Slotta-Huspenina, Kristina Schwamborn, Katja Steiger, et al.
The Journal of Infectious Diseases|December 26, 2019
Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus InfectionEva Loffredo-Verde, Sonakshi Bhattacharjee, Antje Malo, et al.
Cell Death & Disease|May 27, 2026
NF-κB inducing kinase (NIK) deletion accelerates KRAS-driven pancreatic cancer in association with tumor microenvironment remodelingZiwei Du, Ulrike F G Büttner, Hannah Lea Wirth, et al.
The Journal of Pathology|July 13, 2022
Experimental investigation of skin toxicity after immune checkpoint inhibition in combination with radiation therapyLaura Lansink Rotgerink, Hannah Felchle, Annette Feuchtinger, et al.
Plos One|October 3, 2019
A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapyGeorgios Kaissis, Sebastian Ziegelmayer, Fabian Lohöfer, et al.
Endocrine-Related Cancer|January 13, 2018
Inflammation and PD-L1 expression in pulmonary neuroendocrine tumorsAtsuko Kasajima, Yuichi Ishikawa, Ayaka Iwata, et al.
JHEP Reports : Innovation in Hepatology|March 1, 2024
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine componentJinpeng Su, Zahra Harati Taji, Anna D Kosinska, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendixMoritz Jesinghaus, Björn Konukiewitz, Sebastian Foersch, et al.
Scientific Reports|June 17, 2020
Mir34a constrains pancreatic carcinogenesisAna Hidalgo-Sastre, Clara Lubeseder-Martellato, Thomas Engleitner, et al.
The Journal of Pathology. Clinical Research|January 31, 2022
Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?Anna-Lina Herz, Sarah Wisser, Meike Kohlruss, et al.
Pageof 37

Showing results (141-150 of 370) with videos related to

Sort By:
Pageof 37
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized DiseaseJulia Slotta-Huspenina, Kristina Schwamborn, Katja Steiger, et al.
The Journal of Infectious Diseases|December 26, 2019
Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus InfectionEva Loffredo-Verde, Sonakshi Bhattacharjee, Antje Malo, et al.
Cell Death & Disease|May 27, 2026
NF-κB inducing kinase (NIK) deletion accelerates KRAS-driven pancreatic cancer in association with tumor microenvironment remodelingZiwei Du, Ulrike F G Büttner, Hannah Lea Wirth, et al.
The Journal of Pathology|July 13, 2022
Experimental investigation of skin toxicity after immune checkpoint inhibition in combination with radiation therapyLaura Lansink Rotgerink, Hannah Felchle, Annette Feuchtinger, et al.
Plos One|October 3, 2019
A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapyGeorgios Kaissis, Sebastian Ziegelmayer, Fabian Lohöfer, et al.
Endocrine-Related Cancer|January 13, 2018
Inflammation and PD-L1 expression in pulmonary neuroendocrine tumorsAtsuko Kasajima, Yuichi Ishikawa, Ayaka Iwata, et al.
JHEP Reports : Innovation in Hepatology|March 1, 2024
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine componentJinpeng Su, Zahra Harati Taji, Anna D Kosinska, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendixMoritz Jesinghaus, Björn Konukiewitz, Sebastian Foersch, et al.
Scientific Reports|June 17, 2020
Mir34a constrains pancreatic carcinogenesisAna Hidalgo-Sastre, Clara Lubeseder-Martellato, Thomas Engleitner, et al.
The Journal of Pathology. Clinical Research|January 31, 2022
Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?Anna-Lina Herz, Sarah Wisser, Meike Kohlruss, et al.
Pageof 37